Evidence map›Paper›PMID 41324835›Full record

ArticleThe AAPS journal2025

Preclinical Development of GT-14, a Novel Inhibitor of Gα

Mahua Sarkar, Ting Du, Yuan Chen, Yen V Maroney Lawrence, Jing Ma, Shafiq A Khan, Adegboyega K Oyelere, Dong Liang, Song Gao, Huan Xie

Abstract read
In one paragraph

Article in The AAPS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mahua SarkarDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.ORCID 0000-0001-6899-0088
Ting DuDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.ORCID 0000-0002-7705-6913
Yuan ChenDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.ORCID 0000-0001-8676-0913
Yen V Maroney LawrenceDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.ORCID 0009-0003-1720-7358
Jing MaDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.ORCID 0000-0002-9233-0247
Shafiq A KhanCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, 223 James P. Brawley Dr., Atlanta, Georgia, 30314, U.S.A.ORCID 0000-0002-1010-313X
Adegboyega K OyelereSchool of Chemistry and Biochemistry, Parker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, 901 Atlantic Drive, Atlanta, Georgia, 30318, U.S.A.ORCID 0000-0002-2248-9551
Dong LiangDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.ORCID 0000-0001-6632-8066
Song GaoDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.ORCID 0000-0003-2361-3494
Huan XieDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, 3100 Cleburne Street, Houston, Texas, 77004, U.S.A.. huan.xie@tsu.edu.ORCID 0000-0002-0591-5619

Funding

Targeted Nano-drug-delivery-systems of Frist-in-class Drugs for CRPC: PK/PD Evaluation and Combination TherapyU54MD007605 · NIMHD · TEXAS SOUTHERN UNIVERSITY · PI Dong Liang, Huan Xie · 2020 to 2026
$22.0M
NIMHD NIH HHS U54 MD007605
6 · The paper itself

Abstract

GT-14, identified as [(E)-4-((1-(1-methyl-1H-indol-2-yl) ethylidene)amino)phenol], is a novel inhibitor targeting the Gα

Indexed as

IndolesAnimalsCaco-2 CellsDrug DevelopmentDrug Evaluation, PreclinicalHumansHydrogen-Ion ConcentrationMaleMicrosomes, LiverRatsRats, Sprague-DawleySolubilityTissue DistributionIndolesgαi2 proteinmetabolismphysico-chemical propertiespreclinical developmenttissue distribution

Identifiers

PMID41324835
PMCPMC13050480

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.